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Abstract: 
Symptoms of poor memory and concentration represent a common cause of morbidity 
amongst patients presenting to General Practitioners and may result in referral for a 
neurological opinion. In many cases these symptoms do not relate to an underlying 
neurological disease or dementia. In this article we present a personal perspective on the 
differential diagnosis of memory symptoms in the neurology clinic, especially as this 
applies to patients who seek advice about memory problems but have no neurological 
disease process. These overlapping caǮfǯ
categories: 1) mǢ ?Ȍǲnǳ
symptoms that become the focus of attention;  3) isolated  functional memory  disorder in 
which symptoms are outwith 'normal' but not explained by anxiety; 4) health anxiety 
about dementia; 5) memory symptoms as part of another functional disorder; 6) 
rȋȌǤǮ-ǯ
consider in addition are 7) memory symptoms secondary to prescribed medication or 
substance misuse; 8) diseases other than dementia causing memory disorders; 9) 
patients who appear to have functional memory symptoms but then go on to develop 
dementia/another neurological disease and finally 10) exaggeration/malingering. We 
discuss previous attempt to classify the problem of functional memory symptoms, the 
importance of making a positive diagnosis for the patient and the need for large cohort 
studies to better define and manage this large group of patients. 
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Introduction 
Research investigating the causes and prognosis of subjective memory impairment is 
dominated by studies designed to prise out those patients who ultimately progress to 
developing a frank dementia and target them for early intervention.  
By contrast there is a remarkable lack of interest in patients who have memory symptoms, 
entirely unrelated to neurodegenerative disease but never go on to get dementia, or who go on 
to improve spontaneously. 
As neurologists and neuropsychiatrists working in regional neuroscience centres, 
predominantly seeing a younger age group of patients, we are frequently referred patients who 
complain or are concerned about memory symptoms and whose symptoms can be clearly 
identified as unrelated to dementia. These are a neglected group of patients, at high risk of 
iatrogenesis. The number of patients in this group is growing alongside  increased media 
exposure about the horrors of dementia, the need for early detection and the introduction of 
incentives for dementia diagnoses[1].  
In this article we draw on our respective backgrounds in research of functional disorders in 
neurology (JS/AC/MR), neuropsychiatry (AC/PT) and the under 65 cognitive disorders clinic 
(SP/DB/JS/AC/PT) to: give a personal perspective regarding the differential diagnosis of 
memory symptoms that can be positively identified as functional; provide a narrative review of 
the available literature; make suggestions for a more positive diagnostic and treatment 
approach and suggest some directions for future research. 
Terminology is always an issue in this area. We shall use the term Ǯ	ǯǯ
neurological disease process. Most of the disorders we are describing may be classified in DSM-
5 as Conversion (Functional Neurological) Disorder that demands positive evidence that the 
symptom is not related to disease (for example by demonstrating internal inconsistencies or by 
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identifying the symptom as one normally experienced in a healthy population).  In ICD-10 the 
category of dissociative amnesia exists to describe isolated retrograde amnesia but other types 
of presentations of memory problems unrelated to neurological diseases are poorly 
represented.  
We recognise that other terms such as psychogenic, non-ǡǮǯ
have been used in the literature about these presentations. In this context functional memory ǲǳǲǳǡǡages of 
dementia, although we argue that the patients we describe with functional memory disorders 
do represent a subset of those patients as they are labelled by some clinicians.  
 
Epidemiology of Functional Memory Symptoms 
Memory symptoms in the general population 
Everyone knows from experience that memory is fallible. We all occasionally go in to a room 
and forget why we are there, lose track of a conversation or temporarily forget something 
familiar like a PIN Ȃ these things are all part of everyday experience. Data on this has been Ǯ
ǯ[2]. They took hundreds of studies with control data and 
presented the frequency of symptoms in different populations. Table 1 shows some examples of 
this data in young healthy adults emphasising the value of considering the base rate when ǮǯǤ 
Predictably, there is also evidence that these cognitive complaints increase during the lifespan. 
A Dutch study of nearly 2000 healthy subjects found that as many as 29% of people aged 25-35 
considered themselves forgetful, rising to 34% (40-50 years), 41% (55-65) years and 52% 
between 70-85 years[3]. High proportions (47-60%) of these respondents said they were 
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ǮǯǤ
with depression and poor subjective health. Although some attributed them to emotional ǮǯǤ
needs to be put in the context of changing frequencies of mental disorder across the lifespan. 
Anxiety and depression also increase with age with most studies finding an increase in  ? ?ǯ ? ?ǯ[4]. 
 
Studies of memory clinics 
Early studies of memory clinics found high proportions of patients without dementia. A cross-
sectional study of 418  consecutive patients seen at the Institute of Psychiatry in London in the  ? ? ? ? ? ? ?ǮȋȌǯ ? ?
found ǮǯǤThree more recent studies of memory clinics run 
by neurologists in the UK (which usually have a strong bias to seeing patients under 65 years of 
age) give indicate how commonly dementia is not diagnosed now in patients with primary 
cognitive complaints. A study from Liverpool reported rates of 40% in 2006 (n=183)  dropping 
to only 24% (n=252)(Figure 1) [5]. They attribute this to raised awareness of referral guidelines ǮǯǤ 
Similarly a centre in Sheffield reported that the frequency with which presentations in the 
memory clinic were related to neurological or neurodegenerative disorders dropped from 65% 
in 2004 to 45% from 2012 and that functional memory disorders were common in the 
remaining patients [6]ȋ	 ?ȌǤǯ
Disease from Bristol reported that 12% of their patients had this diagnosis with the figure rising 
to 33% in the under 60s.[7]. Functional memory disorder was diagnosed twice as often in 
women as men and 9/19 patients were thought to have invalid neuropsychological results on 
the basis of effort testing. .  
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Cohort studies of Subjective Cognitive Impairment (SCI) and Mild Cognitive Impairment 
(MCI) 
Epidemiological data on SCI and MCI predominantly relates to adults over 65 and even then the 
focus is more on the risk of dementia rather than explaining what is wrong with the other 
patients in the cohorts. It is outwith the scope of the article to discuss definitions and problems 
with the concept of MCI but this usually signifies the presence of memory complaints which are 
abnormal for age but no dementia in combination with normal activities of daily living[8]. 
Nonetheless studies in this area show that up to 40% classified in either category improve 
rather than deteriorate over time.[9][10][11]) Even in this older age group (typically over 65), 
SCI has been found to be associated with anxiety and depression and physical health 
complaints. In a younger age group (age 45-64) psychological distress was the biggest factor 
related to SCI[12] However, the lack of research focus on functional cognitive symptoms means 
that their epidemiology is poorly understood. 
In addition to changes across the lifespan there is some evidence that concern and awareness of 
memory complaints are increasing over time as well. A study examining data from three 
iterations of the British National Survey of Psychiatric Morbidity found evidence that the 
frequency of complaints has been creeping up from 1993 to 2007 (Figure 2)[13] 
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Ǯ-ǯneurology 
clinic 
The following list is not presented as a nosology of mutually exclusive diagnoses, but as a 
description of the most common clinical profiles encountered in memory clinics when no 
evidence of neurodegenerative disorder or neurological disease can be found to explain the ǯǤmay overlap with one another but benefit from 
conceptualisation because they are likely to differ in terms of causation and outcome and 
because they are treated differently. We are not aware of any previous study that has attempted 
to break down these types of complaint among patients attending a memory clinic. 
1. Memory symptoms as part of Depression or Anxiety 
Case: A 58-year-old woman presents with a 6-month history of pervasively low mood and 
anhedonia with suicidal ideation and feelings of worthlessness and guilt. She has also noticed a 
marked decline in her memory, forgetting what people have told her and important appointments. 
Her general practitioner has started an antidepressant but refers her because he is concerned she 
may be developing dementia. 
Complaints of poor memory and concentration are symptoms that forms the basis of diagnostic 
criteria for both major depression and generalised anxiety in DSM[14]. In patients with 
depression, deficits in executive function, attention and memory occur not only during periods 
of low mood but are also detectable during apparent remission [15][16].  Subjective memory 
complaints in depression do not correlate well with objective findings in neuropsychological Ǥǲǳ
neuropsychological tests. Among the more consistent objective findings are a failure of 
executive organisation of memory and overgeneral autobiographical memory [17] (the inability 
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to remember precise details but rather just general impressions ie I went on holiday as opposed 
to I particular enjoyed a specific event whilst on holiday).  
2. ǲǳȀ 
Case: A 25-year-old philosophy student presents with a 6-month history of worsening memory 
complaints. He reports that he always had an excellent memory which was better than that of most 
of his peers. Recently however, he has been somewhat alarmed and puzzled by episodes where he 
has forgotten that he left the tap running, times when he has gone to another room and forgotten 
why he is there and has put unusual objects in the fridge. On questioning, the frequency and nature 
of these episodes appear to be occurring in a range that is normal for the population. He is not 
particularly anxious or depressed, but appears introspective and puzzled. 
Since nearly one third of the population regard themselves as Ǯforgetfulǯ, it is perhaps surprising Ǯǯmemory failures ǯ to health 
professionals. Patients who do find their way to a clinic with symptoms like this often appear to 
have an excessively high expectation of their own memory, an excessively high expectation of 
health services or they have been referred by an inexperienced healthcare practitioner (who 
may be more anxious than the patient!).  Ǯǯe 
arguably a subset of patients with functional memory symptoms and overlap with more general 
health anxieties. However, some patients attend memory clinics whose day-to-day experience Ǯǯrom having this 
explained to them.  
 
3. Functional Memory Disorder (as a relatively isolated disorder) 
Case: A 37-year-old woman is referred by her GP because she has noticed increasing problems with 
her memory. She has cognitive symptoms such as losing track of the conversation, losing objects in 
the house, forgetting where she had read to in a book etc but they appear to be happening much 
more frequently than anyone would expect. She has also noticed some word finding difficulty and 
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occasional spoonerism/neologisms. She explained how she had forgotten her PIN number and 
went completely "blank" and "spaced out". On another occasion she forgot a whole car journey 
home even though she was driving. She can, however, enjoy complex crime dramas and is able to 
relate her history in detail. She is more concerned than her family, although they have often 
noticed the problem.. She has some anxiety about what is wrong but not enough to make a 
diagnosis of an anxiety disorder.  
In ǯand family seem to think there are problems with 
cognitive performance. It would not be appropriate in this case to say that the cognitive failures 
described Ǯǯbelongs to the Ǯǯ. Ǯǯ
as the problem is impacting on social and occupational functioning, and although some of the 
examples of suboptimal cognitive performance Ǯǯ
frequency of them are not. The extent of memory symptoms is also disproportionate to the 
degree of anxiety perceived by the patient and cannot be explained away simply by labelling ǲ-ǳǤ In this scenario that another diagnostic label or formulation is 
required in order to explain to the patient what has happened and to facilitate treatment Ȃ a 
functional memory disorder.   
In our view the core of a functional memory disorder (FMD), like any other functional disorder,  
depends on showing positive features which allow its identification and ensuring that the 
symptoms cannot be explained by another diagnosis. Like in other functional neurological 
disorders, substantial internal inconsistency is an important pointer to the diagnosis of FMD 
(e.g. this patient complains of poor memory function but is able to give a detailed description of 
many memory failures). In addition external inconsistency with what we know happens in 
pathological diseases affecting memory allows greater confidence in the diagnosis. For example, 
consistently forgetting family names but recounting those of doctors seen in detail or notable ǮǯǯǤ
discuss the status and potential clinical features of functional memory disorder below. 
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4. Health Anxiety about Dementia 
A 47-year-old man presents with some relatively minor sounding cognitive symptoms such as 
forgetting where he had got to in a book, forgetting what he had for breakfast. He also had an 
 ? ?ǯ journey. He 
has become terrified that these symptoms represent dementia. His uncle died of Alzheimerǯs at the 
age of 71. He has been reading about dementia online and admits reluctantly that he has been 
worrying constantly about dementing himself soon.  
 
Dementia has an increasingly public profile. Heads of state convene meetings about dementia. 
GPs are paid additional fees for diagnosing dementia. In this context it is reasonable to ask 
whether the downside for all this publicity is the induction of health anxiety about dementia in a 
proportion of the population. Ǯǯ
fear of dementia was coined in 1996 in the adult children of affected parents [18]. More recently Ǯǯ[19][20] ǲ	ǯǳ
described [21] which, unsurprisingly, find that these problems are more common in dementia 
clinic patients without dementia than healthy controls. Health anxiety is defined as anxiety 
about a health condition that only responds temporarily, if at all, to reassurance and is 
associated with some insight. Normal investigations may have the paradoxical effect of 
worsening the condition-Ǯ do a scan Ȃ ǯ
found it, yetǯǤ 
 
A Cochrane review concluded that psychotherapy for health anxiety in general 
(hypochondriasis) showed significant improvement on average across studies [22]. When 
identified treatment of health anxiety is therefore often clinically rewarding. Effective internet 
delivered CBT treatments for health anxiety have also been developed to help improve access 
[23]. However, there is as yet, no specific trials regarding the effectiveness of psychotherapy for ǲǳǤ 
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5. Memory symptoms as part of another functional disorder 
A 39-year-old woman presents with a four-year of history of fatigue and a two-year history of left-
sided weakness, pain and memory symptǤǯ
sign demonstrated that her weakness is functional in nature and appropriate investigations have 
excluded comorbid disease. She has responded well to explanation and rehabilitation and there is 
no ongoing anxiety or depression. On returning to clinic she complains that although her weakness 
has improved, she still has a lot of fatigue and pain and has noticed increasing memory symptoms 
such as forgetting appointments. 
Functional disorders such fibromyalgia, chronic fatigue syndrome and irritable bowel syndrome 
are common in primary and secondary care. The core symptoms of all these disorders include 
sleep disturbance fatigue and, impaired memory and concentration. Studies highlight problems 
with attention, memory and reaction time [24,25]. ǲ-ǳonic whiplash have been associated with similar symptomatology 
and findings on testing. 
Functional Neurological Disorders are characterised by internally inconsistent clinical 
manifestations, such as the left-sided weakness ǯdescribed in the 
case example. Studies in patients with functional movement disorder[26,27] and dissociative 
(non-epileptic) attacks [28][29,30] have highlighted a similar range of cognitive findings to 
other functional disorders..  
Just as it may be appropriate for some patients to consider an anxiety or depressive disorder as 
the predominant cause of their memory symptoms, it may be clinically more appropriate in 
some individuals to consider that memory symptoms are best seen as part of their functional 
somatic disorders. This judgement depends primarily on whether the symptom appears 
proportionate to the functional syndrome previously diagnosed. 
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6. Retrograde dissociative (psychogenic) amnesia 
A 41-year-old university lecturer presents with a dense retrograde amnesia. His family bring him 
to hospital because he had woken up one morning believing that he was 19 years old. He seems 
unable to recognise his wife or children. He was able to acquire new memories but could not recall 
any events from his life after the age of 19. He looked bewildered but was able to use objects such 
as his phone which he would have learnt to use more recently. Over the next few weeks his 
memories gradually returned. He denied any recent stress although admitted to fatigue. He 
returned to work but re-presented a year later with more short-lived episodes lasting a few hours 
in which he felt 19 again. 
ǲǳǲǳence of dense retrograde 
amnesia predating a particular time point usually associated with well-preserved anterograde 
memory and loss of personal identity [31]. This type of memory loss, probably seen as 
commonly in TV and film as it is in clinical practice [32], is usually quite distinct and does not 
show much overlap with the presentations described above. Neurological disorders such as 
brain injury, transient global amnesia or transient epileptic amnesia may also present with 
retrograde amnesia although here there is nearly always anterograde amnesia as well as a Ǯ-ǯǤǡ
be associated with malingering which is an important differential diagnosis of this presentation.  
 
7. Memory Symptoms secondary to prescribed medication or substance misuse 
Case Ȃ A 35-year-old man with a ten-year history of chronic back pain was referred because of 
concerns about his ǤǮǯǮ
ǯǡ
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to read a novel. He was not depressed or anxious. His medication including MST (long acting 
Morphine) at a dose of 160mg twice daily as well as Amitryptiline 150mg, Diazepam 5mg twice 
daily and Gabapentin 900mg three times a day. 
A considerable proportion of patients presenting to under 65 memory clinics and not found to 
be experiencing memory symptoms of neurodegeneration or neurological disease take 
prescribed, over-the-counter or illicit drugs capable of exacerbating cognitive symptoms. In the 
UK many patients with chronic pain syndromes are placed on high dose opiates even when no 
clear cause of the pain can be identified. Evidence is mounting against this approach, 
considering issues such as dependence and tolerance [33]. Surprisingly, there is no consistent 
evidence that opioids adversely affect cognition in chronic non-cancer pain with some studies 
even suggesting an improvement [34]. There seems to be stronger evidence that pain itself is 
associated with impaired cognition [35][24]. However, common-sense does suggest that 
combinations of drugs as above drugs including those with more legitimate roles in functional 
disorders such as pregabalin, gabapentin, topiramate and tricyclic antidepressants can 
significantly impair cognitive function. Sodium valproate, and its potential for 
hyperammonaemic encephalopathy as well as anticholinergics used for bladder symptoms are 
worth a special mention. 
8. Diseases other than Dementia causing Memory Disorders 
There are of course numerous other diseases which cause memory disorder that are not one of 
the primary ǲǳǤcognitive impairment and dementia associated with 
multiple sclerosis, autoimmune encephalitis, paraneoplastic disorders, CNS infections including 
HIV, metabolic disorders such as vitamin B12 deficiency states, transient epileptic amnesia and 
transient global amnesia to name but a few. Some non-neurological disorders such as 
obstructive sleep apnoea may also have effects on memory and concentration. 
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9. Patients who appear to have functional memory symptoms but then go on to develop 
dementia/another neurological disease  
The clinician in the memory clinic must of course be aware of the limitations of any clinical 
diagnosis. Many types of dementia begin with mild symptoms in the prodromal stages, 
commonly anxiety and depression which are more common in the early stages of most 
neurodegenerative disorders than in the general population.  Neurological or medical disorders 
may also be complicated by additional functional symptoms.[36,37] The discovery of such 
symptoms (for instance through internal inconsistencies) should not stop the clinician from 
considering consider whether another disease process is also present  [38]. Patients may also 
develop functional symptoms such as paralysis as part of a prodrome of dementia. A balance 
must be struck between making a positive diagnosis of a functional memory disorder to enable 
treatment to take place, and not missing an underlying progressive disease using judicial follow 
up. It remains to be seen whether advances in neuroimaging and CSF analysis will aid this 
separation, given the likelihood of false positive findings in some of these techniques, such as 
amyloid imaging.  
10. Exaggeration/ Malingering 
Case Ȃ A 42-year-old woman presents for medicolegal assessment seven years after a head injury. 
She has had a psychometric assessment that suggested results compatible with a moderate to 
severe brain injury. Review of the notes indicated that her cognitive symptoms had worsened over 
time and that the initial head injury was not associated with any amnesia or focal deficit. At 
interview she presented in a childlike way, was barely able to interact socially and used a 
wheelchair. She and her husband claimed this was always her level of function. Covert surveillance 
on holiday demonstrated that she could cycle one-handed and was interacting in a normal way 
with friends. 
A comprehensive discussion of this is beyond the scope of this article. The hallmark of 
malingering or exaggeration is the presence of a marked discrepancy between reported and 
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observed function as described here. Someone who has a functional memory disorder should be 
able to report with reasonable accuracy what their normal day to day function and interactions 
are like. Considerable data exists on validity/effort testing mainly in the context of medicolegal 
assessment after brain injury[39]. 
Existing data suggests that effort testing should be a standard part of psychometric assessment, 
(if psychometric assessment is required). Failure of effort testing is not however synonymous 
with deliberate deception. Below chance performance does not necessarily mean that the 
person is wilfully and consciously failing even if it does invalidate other measures[40]. It may 
even be a marker of a functional memory disorder [27].  
 
Clinical Approach to Assessment and Treatment 
Some clinical features of encounters with patients with functional memory symptoms include 
those seen in Table 2. A recent study using conversation analysis of 25 recorded consultations 
(16 of which were considered to be with patients independently diagnosed as having a 
functional memory disorder) examined some of these discriminating factors formally for the 
first time [41]. This exploratory study suggested that the following five factors were of the 
greatest discriminating value: (1) whether the patient is able to answer questions about 
personal inforȋǮǫǯǮǫǯȌǢȋ ?Ȍ
can display working memory in interaction (for example the patient who can recall something 
they said earlier in the consultation); (3) whether they are able to respond to compound 
questions; (for example answering a two part question given by the neurologist )(4) time taken 
to respond to questions (generally being quicker); and 5) the level of detail they offer when 
providing an account of their memory failure experiences (offering more elaboration and detail 
in their responses.   
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An additional feature suggestive of the diagnosis of functional memory disorder highlighted by 
Schmidtke et al was the presence, in the history, of episodes consistent with dissociative lapses, Ǯǯǯ [42]. 
 
Neuropsychological Testing 
In the right hands, neuropsychological testing can be an elegant way to demonstrate some of the 
internal inconsistencies that are the hallmark of a functional memory disorder.  Ideally, this  
should be done with a focus on reporting the whole style of interaction and the way the patient 
responds to testing and not just focusing on scores. Neuropsychological tests results in the 
normal range may also help to reassure patients about their cognitive function. Symptom 
Validity Testing (or Effort testing) may have particular value in legal scenarios 
There is a clinical argument, however, when multiple positive indicators of a functional memory 
disorder are clinically apparent that formal neuropsychometric testing may be unhelpful and 
can sometimes lead to iatrogenic worsening of symptoms. Cognitive assessment may not ǲǳǲǡǳǤ
neurodegeneration, especially when anxiety, depression and effort are not considered. Repeat 
testing after six or twelve months may be recommended. Alternatively referral to dementia or 
head injury self-help groups. may strongly perpetuate the idea that memory symptoms relate to 
brain damage. 
 
Treatment 
Identification and Diagnosis 
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ǯȋȌ
disorders from non-degenerative memory problems may be hard, especially at a stage when 
symptoms are relatively mild.. However, in our experience it is often possible to recognise and 
diagnose functional memory disorder at their first visit. Patients with a functional memory 
disorder should be told as soon as possible what the most likely diagnosis is and why they do 
not have a dementia or are unlikely to be developing it. This approach accepts that dementia, 
usually prodromal dementia, will sometimes be mislabelled as a functional disorder.   
We find Ǯǯelpful in guiding our recognition and 
treatment of memory symptoms unrelated to neurodegenerative disorders. Most patients are Ǯǯ, but a framework such as this may 
allow more targeted treatment and remind clinicians to look, for example, for treatable 
problems such as health anxiety. 
 
Explaining the diagnosis 
As for any explanation we would recommend that the doctor should make it clear where 
possible that: 
(1) That they are taking the problem (and associated disability) seriously both during the 
history-taking and during the discussion of the diagnosis. 
2) There is a diagnosis Ȃ the precise term, e.g. functional memory disorder, may not be as 
important as the principle of applying a diagnosis. Simply telling a patient that Ǯ
dementiaǯ is not sufficient since that does not offer an explanation for the complaints the patient 
has. ǲǳȋȌ
situation. Whilst it is recognised that patients with MCI are at increased risk of progressing to a 
dementia it is an accepted part of the MCI concept that it may not progress or, indeed, 
improve[9][10][11][43]. However, we have significant concerns about the anxiogenic effects of 
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ǮǯǤ
current time the risk is that more harm is done by the over-diagnosis of (presently) irreversible 
neurodegenerative processes than by the early recognition of a possibly . treatable disorders 
causing memory impairment listed above .  
3) There is a rationale for the diagnosis, i.e. it has been made on the basis of positive evidence of 
symptoms and signs that are characteristic of a functional memory disorder. There is no reason 
why the features described above could not be discussed openly with the patient as evidence of 
internal inconsistency that is the hallmark of the diagnosis. For instance, pointing out that the ǯ
give a very detailed account of their concerns can provide a basis for the reassurance that 
patients developing a dementia would not have been able to produce a similar report. This 
would be equivalent to using an explanation of ǯȋȌ
weakness (where hip extension is weak during voluntary movement but improves when 
movement is directed to the contralateral leg) as a therapeutic intervention [44]  
 ?ȌǮǯȋǮǯȌȂ for 
example a discussion about how the symptoms may arise due to poor concentration. Some 
patients appear to develop  an unrealistic  view of how normal memory performs. 
5) That it is potentially reversible and treatment may help. 
6) There is written information to spend longer understanding the problem Ȃ as suggested by a 
Dutch population-based cohort study of subjective forgetfulness [3] 
7) There is a willingness to triage the patient for further treatment and/or follow up the patient 
as required if the symptoms are causing significant disability. 
Further Treatment 
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1. Treatment of Anxiety or Depression. Where present, anxiety or depression should be 
treated using either pharmacological and/or psychological therapies depending on 
circumstances. Significant health anxiety symptoms should be managed with cognitive 
behavioural therapy, other psychotherapeutic or psychoeducational approaches. Other 
disorders such as agoraphobia or obsessive compulsive disorder may become apparent as 
treatment progresses. 
Where the patient seems to have genuine dissociative (psychogenic) retrograde amnesias our 
impression is that more interpersonally directed or trauma related treatment may be more 
efficacious. 
2. Specific issues relating to treatment of functional memory symptoms. A common clinical 
feature of functional memory symptoms are avoidance of using memory and the association of 
memory utilisation with the experience of failure.. A core part of the management of any patient 
involves a Ǥǯ
subtle. For instance they may exhibit an increased dependency on family members and the 
concerned relative will often have to be part of the intervention process.  
These unhelpful thoughts and avoidance can be challenged using typical cognitive therapy 
techniques focusing on inconsistency, (i.e. its works sometimes and not at others) and also 
education about the normal experiences of forgetting. A more detailed guide to challenging 
unhelpful thoughts in functional neurological symptoms disorders can be found elsewhere [45]. 
3. Reduction or avoidance of medications impairing cognition 
4. Regular clinical review is important both to ensure adequate clinical management but also 
to pick up the small number of patients who are in the early stages of a degenerative 
disease. 
 
Previous attempts to define functional memory/cognitive disorders 
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Two groups have attempted to define and study this group of patients. In a series of important 
studies Schmidtke et al described patients attending a memory clinic Ǯ	ǯȋ	Ȍin whom it was felt that the symptoms were not explained by dementia or 
depression (although they did not exclude anxiety disorders)[42]. They defined their patients 
on the basis of having an impairment in functioning, having some evidence of a psychological 
stressor, falling within 1.5 standard deviations of population norms on psychological testing and 
not having dementia or depression. The data highlighted how frequent the problem is in clinical 
practice and also provided interesting follow up data. At a mean of 46 months follow up, one 
patient developed dementia, but only six had improved, lending weight to the idea that most of ǮǯǤ
authors tested a functional memory disorder scale which has many items that appear typical of 
this patient group (Table 2). They subsequently went on to show that cut off scores could 
distinguish healthy controls from these subjects[46]. There is no evidence, however, that it has 
sensitivity or specificity for use against subjects with early onset dementia. 
Delis and Wetter defined a similar patient group as having a Ǯǯ[47]. Their 
paper drew evidence primarily from the large literature surrounding effort/validity testing and 
was biased towards the neuropsychological assessment of claimants after mild head injury. ǡǮǯ
and occupational impairment. They proposed diagnostic criteria based heavily on 
inconsistencies, either or test scores with each other, or of symptoms and test scores with day-
to-day function, something that is missing from the Schmidtke criteria (Table 3). They also 
accounted for the presence of variable intentionality, and the fact that these symptoms may or 
may not cause occupational or social impairment.  
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ǲǳ
here, even if that term is now reserved for patients with severe depression [48]. Subsequent ǲǳ
only rarely been grappled with [49]. 
 
Is there a neuroanatomy of functional memory disorders? 
The answer, inevitably Ǯǯ although this is outside the scope of this review. ǡǲǳ
terms of their neurobiological underpinning. There has been consistent evidence linking 
depressive disorder to reduced volumes in prefrontal cortex and hippocampus [50]. Whilst it is 
tempting to link these structural deficits and memory problems together studies so far have 
demonstrated rather inconsistent findings. Lack of precision in both depression phenotypes and 
cognitive phenotypes may be the issue rather than the absence of any true association. Several 
studies of patients with dissociative /retrograde amnesia have examined potential neural 
mechanisms [31] including dysfunction of temporal lobes and in one of the largest studies of 14 
patients, right inferolateral prefrontal hypometabolism [51]. 
 
Research Priorities 
Despite notable attempts to define the nature of the clinical problem in this area, this is a topic 
that is hugely under-researched given how much time and clinical resources appears to be going 
in to providing assessments for these patients.  In addition there are likely to be substantial 
societal costs from lost time at work and provision of state related benefits. We suggest the 
following important research questions: 
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1. Ǯ-ǯ
occupational or social impairment at a population, primary care and secondary care 
level? 
2. Is it possible to define a group of patients using positive diagnostic criteria based on 
typical symptoms, psychosocial variables with normal test scores (as suggested by 
Schmidtke et al[42]), an approach that positively identifies inconsistencies between 
symptoms, symptoms and performance and within psychometric test scores. (as 
suggested by Delis and Wetter[47]) or perhaps a combination of the two approaches 
3. If we can identify a group of such patients is it possible, and is there clinical value, in 
attempting to separate out the seven types of presentation we have described in this 
paper or in characterising different patient groups using a dimensional approach? 
4. What is the prognosis of these presentations in primary and secondary care and do they 
vary according to the clinical emphasis? For example do those patients with specific 
dementia phobia do better or worse than patients with little health anxiety? 
5. Would making a positive diagnosis of a functional memory disorder enable more 
specific and effective treatment and would this improve prognosis? 
6. Can biomarkers in dementia diagnosis, such as amyloid imaging, PET/SPECT imaging, 
and CSF tau/amyloid be developed to predict a diagnosis of functional memory disorder 
as well as a diagnosis of dementia. 
At this stage we suggest that it is premature to attempt to define diagnostic criteria for a 
problem which has been so poorly studied. Large cohort studies are required to define more 
carefully the clinical characteristics and prognosis of these types of presentations.  
Conclusions 
Functional memory disorders are common in any neurology service but especially in the 
cognitive or memory clinic. They have traditionally been ignored both by clinicians and 
researchers more interested in dementia. Patients with functional memory symptoms are not 
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just the 'worried well' or people with "just anxiety and depression". They represent a variety of 
overlapping phenotypes some of which are associated with significant social and occupational 
impairment and may have different clinical approaches.  Data is beginning to emerge to allow a 
positive diagnosis of a functional memory disorder, with an emphasis on internal inconsistency 
but also other features of the presentation such as dissociative symptoms. Large cohort studies 
are required to take this work forward to a point where the "memory clinic" can help everyone 
with a memory symptom, and not just those with dementia.  
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Figure 1. Proportion of patients in neurology led clinics with a diagnosis of dementia is 
surprisingly low. [5][6] 
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Figure 2. Subjective memory impairment appears to increase over both the lifespan and 
over time. Figure reproduced with permission from Begum et al based on 1993, 2000 and 
2007 English Psychiatric Morbidity Surveys[13] 
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 ?ǤǮǯ
controls[2] 
 
Cognitive Symptom Frequency Reported  
Community Controls Ȃ n=223 mean age 30  
Forgets recent telephone conversation 9% 
Forgets why they entered room 27% 	ǯ 27% 
Forgets where car was parked 32% 
Loses car keys 31% 
Forgets where they went today 5% 
Forgets appointment dates 20% 
Loses  items around house 17% ǲǳ 14% 
College Students Ȃ n=620, age range 17-26  
Memory Gaps 10% 
Speech problems 17% 
Word finding lapses 27% 
Unrecalled behaviour 9% 
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Table 2. A selection of clinical features which may help with the discrimination of 
functional and neurological disease causes of memory disorders. 
Functional  Neurological Diseases 
Young Older 
Attends alone Attends with someone 
Patient more aware of the problem 
than others 
Others more aware of the problem than patient 
Able to detail list of drugs, previous 
interactions with doctors 
Less able 
Watches TV dramas Stops following drama 
Marked variability Less variability 
Types of memory symptom are 
usually within most people's normal 
experience 
Types of memory symptom are often outwith normal 
experiences 
Ǯǯ Ǯǯ 
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Table 3. Comparison and appraisal of previously suggested diagnostic criteria proposed 
for patients with functional memory symptoms[42] [47] 
Functional Memory Disorder[42] Cogniform Disorder[47] 
Complaint of memory symptoms  >6 months Complaints of memory symptoms (outwith normal 
range) OR low scores 
Presence of psychological stress Inconsistencies (two of nine specified) covering: 
Symptoms/scores vs  nature of pathology; 
Variability over time; Evidence of poor effort / 
invalid results; Symptoms vs everyday functioning; 
Delayed onset  or worsening after injury 
Verbal memory and attentional capacity above 1.5 
SD lower limit of normal 
No specific cut off specified 
No organic disease or major psychiatric disorder  
(major depression, psychosis, dissociative 
disorder) found 
Disproportionate to any neurological or 
neuropsychiatric disease present 
 Not intentional (or specify if features of 
malingering or factitious disorder) 
Problems Problems 
Not all patients may have psychological stress, or if 
they do it may revolve around the memory 
symptoms 
Complicated criteria with uncertain validity 
Some patients may score below 1.5 SD but still 
have a functional memory disorder 
Criteria weighted towards medicolegal brain injury 
scenario 
Severe anxiety not included. Functional somatic 
disorders not specified. No mention of drug effects 
No mention of  other supportive features of 
functional memory disorder Ȃ e.g. attending alone, Ǯǯ 
Functional Memory Disorder scale unlikely to 
discriminate between functional disorders and 
dementia 
Unclear how to apply in context of anxiety , 
depression or other somatic symptoms 
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